Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nerv300 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Nerv300

Approved

STANDARD

Nerv300

Azarias Pharmaceutical Laboratories Inc.,🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 29d9da7e7b990d79
Company: Azarias Pharmaceutical Laboratories Inc.,
Type: Standard

Approval Details

Approval Id: 29d9da7e7b990d79
Drug Approval Philippines Name: Nerv300
Product Name: Nerv300
Registration Number: DRP-4910
Brand Name: Nerv300
Generic Name: Vitamin B1 + Vitamin B6 + Vitamin B12
Dosage Form: Capsule
Dosage Strength: 300 mg/100 mg/100 mcg
Manufacturer: Azarias Pharmaceutical Laboratories Inc.,
Issuance Date: 25 October 2023
Expiry Date: 13 November 2028
Pharmacologic Category: Vitamins
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

29d9da7e7b990d79

Type

Standard

Back to Philippines FDA Approvals